Global Non-PVC IV Bags Market - 2021-2028
The global non-PVC IV bags market size was valued US$ XX billion in 2019 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).
Non-PVC IV bags are intravenous bags made of non-PVC (non-polyvinyl chloride) film, which is designed for parenteral nutrition, packaging rehydration solutions, including sodium chloride, glucose, and lactated Ringer's solution, etc., and certain antibiotics and analgesics for hospital and veterinary usage. Moreover, several solutions can be used when collecting blood donations.
Rising Prevalence of Cancer is expected to drive the growth of the market.
There is a growing requirement in oncology treatment, mainly for chemotherapy and targeted drug delivery. Most of these therapeutic agents are likely to interact with the plasticizers and convert them into harmful agents. Moreover, the use of containers can minimalize this discordancy without plasticizers. These bags are made of Polypropylene (PP) and Ethylene-Vinyl Acetate (EVA).
Cancer treatment changes the human body by causing physical obstructions, GI dysfunction, and ulcers and rejects the human body from nutrition. Thus, the nutrition is externally injected. Additionally, the demand for IV bags has risen significantly because of the risen cases of cancer.
For instance, as per World Health Organization (WHO), cancer is the second leading cause of death worldwide. It is estimated 9.6 million deaths, i.e., 1 in 6 deaths, were reported due to cancer in 2018. The American Cancer Society estimated that more than 1.7 million new cancer cases were diagnosed in America in 2019. From the data by Cancer Research U.K., every year, 36,7000 new cancer cases are reported in the U.K. Hence, the increasing prevalence of cancer is the most promising factor for the growth of the IV solutions market.
The friendly habitat of non-PVC IV bags is expected to drive the growth of the market.
Several firms are adapting to plasticizer-free, biologically inert materials to replace PVC (polyvinyl chloride). Moreover, the development and availability of modern materials in different designs have played a significant role in the market by replacing glass and PVC containers. In the past five years, B. Braun has contributed around USD 500.00 million for developing innovative ways to provide PVC and DEHP-free product lines. For instance, In March 2021, Fagron Sterile Services U.S. (FSS), a 503B outsourcing leader, announced a new platform – intravenous (IV) bags – to its product portfolio. Hence, from the above statements, the friendly habitat of non-PVC IV bags is expected to drive the market's growth.
High cost of non-PVC IV bags is expected to hamper the growth of the market.
Non-PVC IV bags are intravenous bags that are made up of non-polyvinyl chloride film. These bags have several advantages, including less pollution, safety, compatibility, lightweight, convenience, and low risk of contamination. Moreover, there is a massive demand for non-PVC IV bags for oncology treatment. Due to the high cost of the product, it isn't easy to reach the end-users, and therefore it leads to hampering the growth of the market.
COVID-19 Impact Analysis:
The sudden outbreak of COVID-19 has positively impacted the non-PVC IV bags. According to the World Health Organisation, it is estimated to be 32,963,318 confirmed cases of COVID-19 till June 3, 2021. Moreover, many people got hospitalized and were on a ventilator; thus, there was no intake of food and water, due to which saline manufacturing was in massive demand. Additionally, the World Health Organization (WHO) has given new guidance on healthcare to strengthen healthcare systems and health security during the COVID-19 pandemic. This factor is predicted to drive the demand for non-PVC IV bags, which is expected to drive market growth.
Single Chamber segmentis expected to hold largest share in this market segment
The single-chamber segment has accounted for the largest revenue share in 2020. The increasing number of point-of-care facilities and home care setups increases the demand for single-chamber bags. The usage of single-chamber products is steadily increasing as IV bags are replaced with other IV containers. Moreover, the approach for non-PVC materials has accelerated replacing glass containers with plastic bags due to the benefits such as ease of handling, transportation, and disposal. Commonly used intravenous solutions include Irrigation fluids, drip bags, and sterile water.
In addition, players are paying close attention to developing customized non-PVC IV bags that can better adjust and scale to suit end-users requirements. Moreover, with the increasing number of local players in the Indian market and in China market, the availability of non-PVC IV bags at competitive pricing is likely to trigger their sales. For instance, in China,
Huaren Pharmaceutical is among the top three leading players in the Non-PVC soft bag infusion sector and has a high market reputation with stable and excellent products. In addition, the peritoneal dialysis solution launched by Huaren Pharmaceutical is the first Non-PVC peritoneal dialysis solution brand in China. The product which it includes is HUAREN dialysis fluid. Hence, from the above statements, the single-chambered market holds the largest segment.
Liquid Mixture segment is expected to hold largest share in this market segment
The liquid mixture segment accounted for the largest revenue share in 2020. The market's growth is because of the implementation of novel designs followed by the high use of IV drips in hospitals. Moreover, major players in the non-PVC IV bags market mainly concentrate on increasing their production to obtain a high market share. For instance, in November 2019, Grifols began the production at its novel blood-collection systems plant in Brazil, with a range of more than 10 million blood collection bags yearly.
In addition, due to increasing demand for specialized IV containers in the blood banks, which can withstand the low temperatures and gives more excellent safety than PVC. Hence liquid mixture segment holds the largest non-PVC IV Bags market.
Ethylene Vinyl Acetate is expected to hold largest share in this market segment
Ethylene Vinyl Acetate (EVA) is expected to witness rapid growth in the future due to usage in blood banks and storage of frozen mixtures. Moreover, increasing recognition and high demand for blood and blood component storage and increasing blood banks around the globe. Thus, from the above statements, the EVA market holds the largest market.
North America region holds the largest market share of global non-PVC IV Bags Market
North America accounted for the largest revenue share in 2020. The demand for IV bags has increased significantly due to the rising prevalence of stomach cancer. Moreover, in US., strict regulations have been imposed to improve patient safety, which in turn increased to non-PVC IV containers. For instance, the American Cancer Society estimated that in 2020 there were about 27,600 cases of stomach cancer in the U.S. The patients who have stomach cancer cannot ingest food through the mouth and thus have to depend on total parenteral solutions for dietary needs and survival entirely. In addition, the rising adoption of novel drug delivery systems and technological innovations grow the demand for EVA infusion bags and is expected to boost the regional market.
The global non-PVC IV bagsmarket is highly competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Baxter, Angiplast Pvt. Ltd., PolyCine GmbH, RENOLIT, Kraton Corp., B. Braun Melsungen AG, Pfizer, Inc., and Shanghai Xin Gen Eco-Technologies Co., Ltd., Jiangxi SanxinMedtec Co., Ltd. and Fresenius Group. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally.
Key Companies to Watch
Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. The company principally focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. Bioscience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine and vaccines. Moreover, Medical Products business produces intravenous products andother products used in delivering fluids and drugs to patients; inhalational anesthetics; contract manufacturing services; and products to treat end-stage kidney disease irreversible kidney failure, including products for peritoneal dialysis and hemodialysis.
Baxter has continuously set standards for manufacturing of intravenous products andother products used in delivering fluids and drugs to patients. For instance, Empty INTRAVIA Container 500 mL.
Why Purchase the Report?
• Visualize the composition of the non-PVC IV Bags marketsegmentation by type, material, content and regionhighlighting the key commercial assets and players.
• Identify commercial opportunities in non-PVC IV Bags market by analyzing trends and co-development deals.
• Excel data sheet with thousands of data points of non-PVC IV Bags market - level 4/5 segmentation.
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
• Product mapping in excel for the key product of all major market players
The global non-PVC IV Bags market report would provide an access to an approx. 66market data table, 64 figures and 200pages.
• Service Providers/ Buyers
• Industry Investors/Investment Bankers
• Education & Research Institutes
• Research Professionals
• Emerging Companies
Global Non-PVC IV Bags Market - By Type
Global Non-PVC IV Bags Market - By Material
• Ployethylene IV Bag
• Polypropylene (PP) IV Bag
• Ethylene-vinyl acetate (EVA) IV Bag
Global Non-PVC IV Bags Market – By Content
• Frozen Mixture
• Liquid Mixture
Global Non-PVC IV Bags Market - By Region
• North America
• Middle East & Africa
• South America
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook